These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
200 related articles for article (PubMed ID: 10390212)
1. Safety and efficacy of intravenous zanamivir in preventing experimental human influenza A virus infection. Calfee DP; Peng AW; Cass LM; Lobo M; Hayden FG Antimicrob Agents Chemother; 1999 Jul; 43(7):1616-20. PubMed ID: 10390212 [TBL] [Abstract][Full Text] [Related]
2. Safety and efficacy of once daily intranasal zanamivir in preventing experimental human influenza A infection. Calfee DP; Peng AW; Hussey EK; Lobo M; Hayden FG Antivir Ther; 1999; 4(3):143-9. PubMed ID: 12731753 [TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of the neuraminidase inhibitor zanamivir in the treatment of influenzavirus infections. GG167 Influenza Study Group. Hayden FG; Osterhaus AD; Treanor JJ; Fleming DM; Aoki FY; Nicholson KG; Bohnen AM; Hirst HM; Keene O; Wightman K N Engl J Med; 1997 Sep; 337(13):874-80. PubMed ID: 9302301 [TBL] [Abstract][Full Text] [Related]
4. Safety and efficacy of the neuraminidase inhibitor GG167 in experimental human influenza. Hayden FG; Treanor JJ; Betts RF; Lobo M; Esinhart JD; Hussey EK JAMA; 1996 Jan 24-31; 275(4):295-9. PubMed ID: 8544269 [TBL] [Abstract][Full Text] [Related]
5. Clinical efficacy and safety of the orally inhaled neuraminidase inhibitor zanamivir in the treatment of influenza: a randomized, double-blind, placebo-controlled European study. Mäkelä MJ; Pauksens K; Rostila T; Fleming DM; Man CY; Keene ON; Webster A J Infect; 2000 Jan; 40(1):42-8. PubMed ID: 10762110 [TBL] [Abstract][Full Text] [Related]
6. Safety and efficacy of the neuraminidase inhibitor zanamivir in treating influenza virus infection in adults: results from Japan. GG167 Group. Matsumoto K; Ogawa N; Nerome K; Numazaki Y; Kawakami Y; Shirato K; Arakawa M; Kudoh S; Shimokata K; Nakajima S; Yamakido M; Kashiwagi S; Nagatake T Antivir Ther; 1999; 4(2):61-8. PubMed ID: 10682150 [TBL] [Abstract][Full Text] [Related]
8. Randomised trial of efficacy and safety of inhaled zanamivir in treatment of influenza A and B virus infections. The MIST (Management of Influenza in the Southern Hemisphere Trialists) Study Group. Lancet; 1998 Dec; 352(9144):1877-81. PubMed ID: 9863784 [TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of the neuraminidase inhibitor zanamivirin the treatment of influenza A and B virus infections. Monto AS; Fleming DM; Henry D; de Groot R; Makela M; Klein T; Elliott M; Keene ON; Man CY J Infect Dis; 1999 Aug; 180(2):254-61. PubMed ID: 10395837 [TBL] [Abstract][Full Text] [Related]
10. Use of the oral neuraminidase inhibitor oseltamivir in experimental human influenza: randomized controlled trials for prevention and treatment. Hayden FG; Treanor JJ; Fritz RS; Lobo M; Betts RF; Miller M; Kinnersley N; Mills RG; Ward P; Straus SE JAMA; 1999 Oct; 282(13):1240-6. PubMed ID: 10517426 [TBL] [Abstract][Full Text] [Related]
11. Zanamivir in the prevention of influenza among healthy adults: a randomized controlled trial. Monto AS; Robinson DP; Herlocher ML; Hinson JM; Elliott MJ; Crisp A JAMA; 1999 Jul; 282(1):31-5. PubMed ID: 10404908 [TBL] [Abstract][Full Text] [Related]
12. Nasal cytokine and chemokine responses in experimental influenza A virus infection: results of a placebo-controlled trial of intravenous zanamivir treatment. Fritz RS; Hayden FG; Calfee DP; Cass LM; Peng AW; Alvord WG; Strober W; Straus SE J Infect Dis; 1999 Sep; 180(3):586-93. PubMed ID: 10438343 [TBL] [Abstract][Full Text] [Related]
13. Neuraminidase inhibitors for preventing and treating influenza in children. Wang K; Shun-Shin M; Gill P; Perera R; Harnden A Cochrane Database Syst Rev; 2012 Jan; 1():CD002744. PubMed ID: 22258949 [TBL] [Abstract][Full Text] [Related]
15. Neuraminidase inhibitors for treatment of influenza A and B infections. MMWR Recomm Rep; 1999 Dec; 48(RR-14):1-9. PubMed ID: 10632443 [TBL] [Abstract][Full Text] [Related]
16. Effect of zanamivir on duration and resolution of influenza symptoms. Monto AS; Moult AB; Sharp SJ Clin Ther; 2000 Nov; 22(11):1294-305. PubMed ID: 11117654 [TBL] [Abstract][Full Text] [Related]
17. Effects of the neuraminidase inhibitor zanamavir on otologic manifestations of experimental human influenza. Walker JB; Hussey EK; Treanor JJ; Montalvo A; Hayden FG J Infect Dis; 1997 Dec; 176(6):1417-22. PubMed ID: 9395349 [TBL] [Abstract][Full Text] [Related]
18. Inhaled zanamivir for the prevention of influenza in families. Zanamivir Family Study Group. Hayden FG; Gubareva LV; Monto AS; Klein TC; Elliot MJ; Hammond JM; Sharp SJ; Ossi MJ; N Engl J Med; 2000 Nov; 343(18):1282-9. PubMed ID: 11058672 [TBL] [Abstract][Full Text] [Related]
19. Zanamivir for treatment of symptomatic influenza A and B infection in children five to twelve years of age: a randomized controlled trial. Hedrick JA; Barzilai A; Behre U; Henderson FW; Hammond J; Reilly L; Keene O Pediatr Infect Dis J; 2000 May; 19(5):410-7. PubMed ID: 10819336 [TBL] [Abstract][Full Text] [Related]
20. Neuraminidase inhibitors for preventing and treating influenza in children. Matheson NJ; Symmonds-Abrahams M; Sheikh A; Shepperd S; Harnden A Cochrane Database Syst Rev; 2003; (3):CD002744. PubMed ID: 12917931 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]